
aluxum/E+ via Getty Images
RxSight (NASDAQ:RXST) has been downgraded by Wells Fargo and BTIG following a second consecutive quarter of 'disappointing results'.
Wells Fargo cut rating for RSXT to EqualWeight from OverWeight, while BTIG cut rating to Neutral from Buy.
The stock is down